Healthcare Enterprise Group market a product called "Ebiox" which is one of a very few that can kill most bacteria including the MRSA superbug. HCEG has contracts with some NHS hospitals at present, but given the recent and current news and public attention, HCEG should be a good bet for a steady rise as more places seek to cut the number of casualties from this infection. HCEG also market abroad in USA, so the potential market for this unique product is massive indeed.

Well worth a punt IMHO

Check it out for yourself

Not a good start today. Why?

This was posted on AFX yesterday, I'd say its positive. I'm ignoring the dip this am;


Healthcare Enterprise optimistic about FY; seeks acquisitions ( )
LONDON (AFX) - Healthcare Enterprise Group PLC said it is optimistic about

the current year after seeing continued progress in its core product distribution unit and important developments in other businesses.
The company also said it continues to explore acquisition opportunities in the occupational healthcare and first aid sectors.

What is the difference between HCEG and HCEW, does anyone know. Is this the warrant price.

This morning RNS announcement:

LPMCC, a major shareholder, granted 110,392, 544 options over shares and warrants to 4 directors.
LPMCC is owned by Stuart Brook (EC) and Michael Low (CEO) and owns 22% of HCEG.
Stuart Brook owns 80%, Michael Low 20% of London Pacific Development (LLC) which which owns 96.5% LPMCC.
Could this be the reason for the drop in price today?

Hotrott, You are correct in your assumption, HCEW does indeed relate to the warrant price.

Angi, I feel it probably has more to do with the predicted time scale of forthcoming events, i.e. punters who were after the quick return jumping ship, still a good long term punt imho.

I thought HCEW was thanks for the confirmation Loadsadosh.

A big 10,000,000 buy this afternoon !!

Interesting article on the BBC News website. A watchdog (the National Patient SafetyAgency) has recommended that hospitals provide hand gel beside patients beds to encourage staff to wash their hands in an effort to beat MRSA. This looks like a good opportunity for HCEG to get sales of Ebiox rolling.

See the full article here:
http://news.bbc.co.uk/1/hi/health/3614058.stm

Anounced on the TV news today, following a trial in several hospitals with good results, the hand gel bottle will be placed at the bed of each patient to be used by Doctors and nurses. This scheme will be rolled out nationwide and is expected to reduce deaths by 450 a year. I hope!!- I hope they are using the gel made by HCEG but why isn't the company announcing any trading update?

I have read elsewhere that the NPSA are evaluating EBIOX along with the data supplied by HCEG next week.

http://81.144.177.110/display?contentId=3258

the link is for the NPSA website where we can keep upto date with their (NPSA) offerings.

Pleased to see this stock moving north

Interesting article here

News-Medical.Net MRSA bugs immunity to hospital disinfectants and antiseptic

Posted By: News-Medical in Medical Patent News
Published: Wednesday, 8-Sep-2004



Dangerous multi-drug-resistant bacteria are also developing immunity to hospital disinfectants and antiseptics, according to new research presented today at the Society for General Microbiologys 155th Meeting at Trinity College Dublin.
Some of the most worrying microbes around, the drug-resistant bacteria known as MRSA (methicillin-resistant Staphylococcus aureus) have been discovered in heavily disinfected hospital locations such as catheters and on the disinfectant soap dispensers used in wards.



http://www.news-medical.net/?id=4581

Todays Shares Magazine has an article "Superbug Blitz".
Very dissapointing that HCEG nor Ebiox do not get a mention.

some big share trades today upto 45,000,000 so far

extract from Hansard today.

Mr. Lansley: I must remind the Secretary of State that the motion refers to many other ways in which failings in action have been laid bare by the NAO report. I will not be able to detail them all, but I want to ensure that the House is aware of them.

8 Sept 2004 : Column 790

"In a debate in July, my right hon. Friend the Member for Hitchin and Harpenden (Mr. Lilley) made specific reference to several new products and processes that have been offered to the NHS. He is not able to vouch for their effectivenessnor am Ibut that is why a rapid review process should be established. Ebiox is a non-alcohol cleansing product."

At long last things maybe beginning to happen.

http://www.publications.parliament.uk/pa/cm200304/cmhansrd/cm040908/debtext/40908-23.htm

Puzzled by the Shares article which mentions neither HCEG nor Bioquell (BQE). I suspect it is an article written by a journalist asked to do some brief research who has picked up just part of the story. Though I would check through this bb for enlightenment but may be just more confused. Can anyone give an objective view of (a) the relative merits of the different technologies attemting to tackle MRSA; (b) the timescale on profitability of the companies involved? I looked at HCEG when written up as a "penny share" in Shares, which was somewhat ludicrous when there are 2.9 billion of them (why so many?). The cap. of HCEG and Bioquell is broadly similar: HCEG have bought rights to EBIOX and it appears on-going research from the inventor; Bioquell have developed their own technology. The former appears to be primarily a marketing company, the latter a technology company. Bioquell's recent announcements concern academic research and two successful projects in French hospitals. Any insights?
Eric

Eric all info here.

http://www.advfn.com/cmn/fbb/thread.php3?id=6399024&from=1

Bioquell totally different product and believe they in effect steam clean rooms.They have also only cleaned a couple.The MRSA bug is carried thru the air,and 99% of us carry it to varying degrees,therefore hitting the source is the more important and that is where HCEG have a distinct advantage.

Below is a write up by citywire a while ago.
Citywire article
----------------
Bugs beware: Healthcare Enterprise is after you
Published: 09:42 Thr 26 Feb 2004
By Algernon Craig Hall, Secret Buying Correspondent

Big news for Healthcare Enterprise Group; the NHS has found its Ebiox product to be an effective solution for eradicating bacteria including the MRSA 'superbug'.

Testing has found Ebiox to be incredibly efficient at removing then destroying bacteria from two key areas hands and bacteria-laden work surfaces and floors.

The cleaning process using Ebiox also works in 30 seconds compared with normal standards which require a killing effect within five minutes.

Ebiox can now start to be used in hospitals which could lead to big orders. There is growing concern about the spread of disease inside hospitals, especially the so call superbug, and effective and quick decontamination has the potential to be very effective in tackling the problem.

Ebiox is one of a number of exciting projects that Healthcare has invested in. The company also makes and distributes occupational healthcare products such as Ebiox's decontaminants and first aid kits and is aiming to act as a consolidator in this fragmented sector. In addition it runs a related consultancy business which has a good US presence and is looking to expand in the UK.

Hope of some use.

Rumour of the day



Healthcare Enterprise, the AIM-listed medical products group, held steady at 1.89p, despite murmurs that it is set to disclose details of a new application for Ebiox in the US on or before its first-half results early next month. The Ebiox range comprises disinfectants used to combat hospital-acquired infections

http://www.timesonline.co.uk/newspaper/0,,2727-1308426,00.html

Quite interesting Ebiox should have an application in the US. Last week, on the Scottish news, the hospitals were discussing using a hand disinfectant sourced from the US - felt like ringing them up and suggesting they consider home grown product!! The US product looked to be serving exactly the same role as I understand Ebiox does.

If it's in The Times it must be correct. now upto 1.92p on bid